Researcher
Stephanie Du Four
- Keywords:Medicine
Affiliations
- Neuroprotection & Neuromodulation (Research group)
Member
From12 May 2023 → Today - Neurosurgery (Department)
Member
From2 Nov 2021 → Today - Neurosurgery (Department)
Member
From2 Nov 2021 → 13 Feb 2022 - Neurosurgery (Department)
Member
From1 Aug 2016 → 31 Oct 2021 - Faculty of Medicine and Pharmacy (Faculty)
Member
From6 Aug 2015 → 27 Jan 2016 - Neurology (Department)
Member
From1 Aug 2015 → 31 Jul 2016 - Faculty of Medicine and Pharmacy (Faculty)
Member
From23 Oct 2014 → 30 Apr 2020 - Clinical sciences (Department)
Member
From1 Jan 2014 → 31 Jul 2015 - Neurosurgery (Department)
Member
From1 Jan 2013 → 31 Jul 2015 - Faculty of Medicine and Pharmacy (Faculty)
Member
From14 Sep 2011 → 6 Jun 2014 - Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From1 Sep 2011 → 19 Mar 2021 - Physiology (Department)
Member
From1 Sep 2011 → 31 Dec 2013 - Neurology (Department)
Member
From1 Aug 2011 → 31 Dec 2012 - Faculty of Medicine and Pharmacy (Faculty)
Member
From23 Aug 2007 → 8 Jul 2011
Publications
1 - 10 of 26
- Nonprogrammable Shunts for Communicating Hydrocephalus and Three-Dimensional Volumetry(2023)
Authors: Jeroen Cortier, Robin Van der Straeten, Frederick Van Gestel, Johnny Duerinck, Vera Van Velthoven, Michael Bruneau, Stephanie Du Four
Pages: e613-e620 - Pituitary carcinoma - case series and review of the literature(2022)
Authors: Stephanie Du Four, Jorn Van Der Veken, Johnny Duerinck, Elle Vermeulen, Corina Andreescu, Michael Bruneau, Bart Neyns, Harry Van Velthoven, Brigitte Velkeniers-Hoebanckx
- Randomized Trial Comparing Burr Hole Craniostomy, Minicraniotomy, and Twist Drill Craniostomy for Treatment of Chronic Subdural Hematoma(2022)
Authors: Johnny Duerinck, Jorn Van Der Veken, Sophie Schuind, Frank Van Calenbergh, Johannes van Loon, Stephanie Du Four, Servaes Debacker, Emmanuel Costa, Christian Raftopoulos, Olivier De Witte, et al.
Pages: 304-311 - Quality indicators in neuro-oncology(2022)
Authors: Dimitri Vanhauwaert, Harry Pinson, Caroline Sweldens, Stephanie Du Four, Liesbet Van Eycken, Harlinde De Schutter, Steven De Vleeschouwer, Tom Boterberg
Pages: 365-376 - Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)(2020)
Authors: Gil Awada, Laila Ben Salama, Jennifer De Cremer, Julia Katharina Schwarze, Lydia Fischbuch, Laura Seynaeve, Stephanie Du Four, A Vanbinst, Alex Michotte, Hendrik Everaert, et al.
Pages: 1-12 - Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab(2018)
Authors: Stephanie Du Four, Yanina Jansen, Alex Michotte, A Vanbinst, Robbe Van den Begin, Johnny Duerinck, Bart Neyns
Pages: 4870-4879 - Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis(2018)
Authors: Wietse Wiels, Stephanie Du Four, Laura Seynaeve, Anja Flamez, Thomas Tousseyn, Dietmar Thal, Miguel D'Haeseleer
- Meningoencephaloradiculitis following infection with tick borne encephalitis virus(2018)
Authors: Stephanie Du Four, R. Mertens, Wietse Wiels, Jacques De Keyser, Véronique Bissay, Anja Flamez
Pages: 93-96 - Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma(2018)
Authors: Johnny Duerinck, Stephanie Du Four, F Bouttens, C. Andre, V Verschaeve, F Van Fraeyenhove, C. Chaskis, Nicky D'haene, Marie Le Mercier, Anne Rogiers, et al.
Pages: 115-125 - Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report(2016)
Authors: Marieke Demeulenaere, Stephanie Du Four, Karel Fostier
Pages: 4145-4149